Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Winners Column: Here are the top 50 ASX small cap stocks for December
Health & Biotech
Check Up: Joining ‘observational study’ sends Avecho shares soaring
Health & Biotech
Creso Pharma receives first pet-health cannabis orders in Latin America
Health & Biotech
Creso Pharma’s CBD medicines will be available prescription free in Australia
News
Weekly ASX small cap wrap: Who are the cup winners and wooden spoon recipients?
Experts
ScoPo’s health powerplays: ‘Cannabis stocks went on a ride’
Health & Biotech
Creso Pharma signs deal with natural lifestyle brand supplier Martin & Pleasance
News
10 at 10: These ASX stocks have surprised their shareholders this morning
Health & Biotech
Weed Week: Cannabis is back with a bang as stars finally begin to align
News
Cannabis stocks take a well-earned breather after days of strong gains
News
Check Up: Creso Pharma gets really, really high; leads ASX health sector
Health & Biotech
Creso Pharma subsidiary expands into Canada’s biggest recreational market
News
ASX Small Cap Lunch Wrap: Who’s getting jabbed today?
News
10 at 10: These ASX stocks are liquid hot this morning
Health & Biotech
ASX pot stocks keep climbing after US House vote; now up 52 per cent in a month
Health & Biotech
Creso Pharma hails US House vote to decriminalise cannabis at federal level
News